Role of endothelin-1 receptor blockers on hemodynamic parameters and oxidative stress
Authors:
- Aleksandra PiechotaAPAleksandra Piechota
- Andrzej PolańczykAndrzej Polańczyk
- Anna GorącaAGAnna Gorąca
- 1 January 2010
- journal article
- review article
- Published by Springer Nature in Pharmacological Reports
- Vol. 62 (1) , 28-34
Abstract
Endothelin (ET) was first isolated and described by Yanagisawa et al. and has since been described as one of the most potent known vasoconstrictor compounds. ET-1 mediates its effects via two types of receptors, ETA and ETB, which are expressed in the vascular smooth muscle cells, endothelial cells, intestines and brain. Secretion of ET-1 results in long-lasting vasoconstriction, increased blood pressure and, in turn, overproduction of free radicals. As dysregulation of the endothelin system is an important factor in the pathogenesis of several diseases including atherosclerosis, hypertension and endotoxic shock, the ETA and ETB receptors are attractive therapeutic targets for treatment of these disorders. The biosynthesis and release of ET-1 are regulated at the transcriptional level. Studies have shown that p38MAP kinase, nuclear factor kappaB (NF-kappaB), PKC/ERK and JNK/c-Jun all take part in the ROS-activated production of ET-1. Furthermore, administration of ET(A) significantly reduces the generation of free radicals. However, treatment with ETB receptor blockers does not elicit the same effect. Therefore, the effects of endothelin receptor blockers on blood pressure and the generation of free radicals remain debatable. This review summarizes recent investigations into the role of endothelin receptor blockers with respect to the modulation of hemodynamic parameters and the generation of free radicals.Keywords
This publication has 59 references indexed in Scilit:
- Endothelin-1 Is Not Predictive of Ventricular Ectopy or Ventricular Fibrillation during Acute Myocardial IschemiaJournal of Interferon & Cytokine Research, 2008
- Endothelin (ET)‐1 and ET‐3 promote expression ofc‐fosandc‐junin human choriocarcinoma via ETBreceptor‐mediated Gi‐ and Gq‐pathways and MAP kinase activationBritish Journal of Pharmacology, 2008
- Effect of adrenomedullin on hepatic damage in hepatic ischaemia/reperfusion injury in ratsLiver International, 2008
- Endothelin-1 Regulates Astrocyte Proliferation and Reactive Gliosis via a JNK/c-Jun Signaling PathwayJournal of Neuroscience, 2008
- Toll-Like Receptor-4 Deficiency Attenuates Doxorubicin-Induced Cardiomyopathy in MiceEuropean Journal of Heart Failure, 2008
- Chronic endothelin‐A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic ratsBritish Journal of Pharmacology, 2007
- ET A Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt HypertensionHypertension, 2003
- NADPH Oxidase–Derived Superoxide Augments Endothelin-1–Induced Venoconstriction in Mineralocorticoid HypertensionHypertension, 2003
- Endothelin-1 Is Produced and Secreted by Neonatal Rat Cardiac Myocytes in VitroBiochemical and Biophysical Research Communications, 1993
- Regulation of endothelin-1 synthesis in cultured guinea pig airway epithelial cells by various cytokinesBiochemical and Biophysical Research Communications, 1992